Serodus serodus.com

Serodus is a Norwegian drug development company, focusing on new therapeutic products for the treatment of cardiovascular diseases with large unmet clinical needs. Two of the company's products are ready for clinical Phase II Proof-of-Concept studies in patients with isolated systolic hypertension and heart failure respectively. The company's business model is to seek partnering with international pharmaceutical companies after having demonstrated clinical effect in humans.

Serodus is a Norwegian drug development company, focusing on new therapeutic products for the treatment of cardiovascular diseases with large unmet clinical needs. Two of the company's products are ready for clinical Phase II Proof-of-Concept studies...Show all

See All Exits Recent Exits

Phone: +47 22 95 81 91

Fax:

Gaustadalléen 21

Oslo, N-0349
Norway

Serodus - Investments & Acquisitions

Show Real Data Serodus Investments
See all Recent Investments
Date Company Round Amount Co-investors
2013-07-10PhlogoMerger
See all 1 investments